Skip to main content
Day.News — Local News. Real Community.
NEW BERN DAY NEWS
Local News. Real Community.

Health & Wellness

08/16/2026 · New Bern

Full Edition

Home Oxygen Access Challenges Delay Hospital Discharges Nationwide

A recent national survey indicates that restricted access to high-flow home oxygen equipment prolongs patient stays in hospitals. These delays reportedly increase both financial burdens and health risks for individuals. The issue also impacts healthcare system costs.

07/29/2026
Read Story
Health

FDA Approves Oral PCSK9 Inhibitor for Cholesterol Reduction

The U.S. Food and Drug Administration has approved Lipfendra (enlicitide), an oral medication designed to lower LDL cholesterol. This approval marks the first time an oral PCSK9 inhibitor has received authorization for use in adults with high cholesterol.

07/27/2026 · North Carolina

Health

Cyclospora Outbreak Linked to Taco Bell Lettuce in Five States

A Cyclospora outbreak has resulted in 1,644 reported illnesses across five states. Authorities attribute the infections to shredded iceberg lettuce served at Taco Bell restaurants. The CDC has issued a public health advisory regarding the consumption of this product.

07/27/2026 · North Carolina

Health

Healthcare-Associated Infections Declined in 2023, CDC Reports

New data from the Centers for Disease Control and Prevention indicates a decline in healthcare-associated infections during 2023. These findings highlight changes within patient safety initiatives.

07/26/2026 · North Carolina

Health

FDA Proposes Rule to Enhance Oversight of Foreign Tobacco Products

The U.S. Food and Drug Administration has proposed a new rule to strengthen its ability to identify and block illegally imported foreign tobacco products. This measure seeks to protect public health by preventing unauthorized tobacco from entering the U.S. market.

07/21/2026 · North Carolina

Health

FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease

The U.S. Food and Drug Administration has granted supplemental approval for Casgevy, a gene therapy. This approval targets children aged two years and older with sickle cell disease or transfusion-dependent beta thalassemia.

07/21/2026 · North Carolina

Advertisement

Advertisement